Alentis Therapeutics AG
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreThese trailblazers have scaled beyond expectations—becoming industry leaders, job creators, and global ambassadors of Swiss excellence. Their journeys reflect the power of vision, resilience, and innovation. Discover the startups that are transforming industries and inspiring the world shapers of tomorrow.
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreGlycobiology and protein degradation
Read moreBringing real emotion to virtual reality
Read moreOnline tools to edit PDFs
Read moreDeveloping cures for serious human genetic diseases
Read moreInstruments for dynamic signal analysis
Read moreNext Generation of Topical Ophthalmic Treatments
Read moreDigital asset specialist with global reach
Read more